Study to Determine the Effects of Nebivolol and Hydrochlorothiazide in African Americans With Hypertension

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The main purpose of this study is to evaluate the effects of Nebivolol and Hydrochlorothiazide on blood pressure in African Americans with high blood pressure.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: InVasc Therapeutics, Inc.
• Treatments: Hydrochlorothiazide; Nebivolol

Criteria

Inclusion Criteria:

• Known Hypertension by history

• Self-described African American

Exclusion Criteria:

• Uncontrolled Diabetes Mellitus (HbA1C>10)

• Known CAD, Cerebrovascular Disease, PVD or Renovascular Disease

• Liver disease

• Chronic Renal Disease

• Uncontrolled Hypertension (>199 systolic and/or >115)